The World's First RNA Anti-Hair-Loss Cosmetic· Trusted Worldwide, Now in India

Skintressence presents

Nobel Prize-winning scienceBuilt on RNA interference · 2006 Nobel Prize

One drop of science.

CosmeRNA ARI Intensive

For Men & Women
  • The world's first RNA-powered anti-hair-loss tonic
  • Korea's breakthrough in hair science
  • Used successfully worldwide — now arriving in India

Brought to India by Skintressence Pvt Ltd · A first-of-its-kind launch

CosmeRNA · One Drop of Science

Cosmoprof 2024 Winner

Hair products category

Dermatest “Excellent”

Independent 5-star safety

Topical, Non-Systemic

Acts only where applied

Once a Week

Long-acting by design

The Breakthrough

A New Era of Hair Care, Written in RNA

CosmeRNA brings siRNA — small interfering RNA — out of the laboratory and onto the scalp, for the first time in a cosmetic.

How siRNA works

It silences the signal at the source

Hair thinning is driven at the follicle by the androgen receptor. CosmeRNA's active, SAMiRNA-AR68, is designed to target the messenger RNA behind that receptor — quietening the signal precisely where it begins, topically, without acting on the rest of the body. This is RNA interference: the gene-silencing mechanism awarded the 2006 Nobel Prize in Physiology or Medicine.

~80 Nanometres

Built to reach the follicle

Engineered at around 80nm, SAMiRNA-AR68 is designed to travel into the follicle — aided by gentle massage with the silicone-tip applicator.

Long-Acting

Just once a week

Thanks to the intrinsic longevity of siRNA inside the cell, a single application once a week is designed to be enough.

Safety

Topical application

Because it acts locally rather than systemically, CosmeRNA is positioned as a gentle option in the hair-care category. No adverse skin reaction reported.

Korean Innovation

From Bioneer's RNA labs

Developed by Bioneer Corporation — a Korean biotech pioneer with in-house capability from RNA research through to raw-material production.

91%

of participants responded positively to changes in scalp condition in an independent CRO (Ellead) study.

Scientific Reports

The mechanism of action and human application results of SAMiRNA® have been published in the international journal Scientific Reports.

EMJ Dermatology

The European Medical Journal highlighted CosmeRNA as a new-concept scalp care cosmetic based on RNA technology.

CosmeRNA · One Drop of Science

The Product

CosmeRNA ARI IntensiveAnti-Hair-Loss Tonic

An award-winning tonic that pairs Bioneer's SAMiRNA® science with an elegant, fuss-free ritual — for men and women experiencing thinning hair.

  • Format: 1 ml tonic with an integrated silicone-tip applicator for targeted, massage-assisted delivery.
  • Use: Once a week on the areas of concern — no daily routine, no rinse.
  • Feel: Lightweight and non-greasy; leaves no residue on the scalp or hair.
  • For: Adults — men and women — seeking to address visible thinning.

The Ritual

A simple routine, once a week

1

Cleanse & Dry

Cleanse the scalp with a gentle shampoo and dry completely before application.

2

Apply with the Tip

Use one ampoule, applying section by section to thinning areas — crown, hairline, part.

3

Massage In

Massage gently for about one minute to aid targeted delivery. Do not rinse.

4

Leave On

Leave on the scalp for 12 hours. Repeat once a week.

Before & After

Clinically Tested. Proven Results.

Documented before-and-after cases in men and women over a programme of consistent use. Individual results vary.

CosmeRNA before-and-after results — female and male cases over 8 to 36 weeks of use

Individual results may vary. Images courtesy of Bioneer Corporation.

Compliance & Trust

Authentic, certified, and compliant

CDSCO Cosmetic Registration

Registration for the Indian market is in progress; imported and handled per regulation.

Authentic Korean Stock

Fully imported, genuine product sourced directly through the authorised channel.

Dermatologist Certified

Awarded an “Excellent” 5-star rating by Germany's Dermatest for skin safety.

Cosmetic, Not a Drug

Notified as a cosmetic in the EU/UK. Not intended to diagnose or treat disease.

For Clinics, Dermatologists & Distributors

Bring CosmeRNA to your patients

Skintressence partners with dermatology and trichology clinics, aesthetic practices and premium salons across India.

Good to Know

Questions, answered

It is the world's first anti-hair-loss cosmetic built on SAMiRNA® (Self-Assembled Micelle interfering RNA). Rather than only conditioning the surface, it is designed to act topically at the follicle. It won its category at Cosmoprof 2024.

CosmeRNA uses RNA interference — the gene-silencing mechanism awarded the 2006 Nobel Prize in Physiology or Medicine. Its active, SAMiRNA-AR68, is designed to reduce androgen-receptor activity at the follicle, addressing a key driver of thinning precisely where it begins.

The product is clinically tested to enhance the appearance of thicker, fuller-looking hair over a programme of roughly 16–20 weeks of consistent use. In an independent study, 91% of participants responded positively to changes in their scalp condition. Individual results vary.

CosmeRNA acts topically rather than systemically and carries an “Excellent” 5-star Dermatest safety rating, with no adverse skin reactions reported in testing. It is gentle enough for sensitive skin. Always follow the enclosed guidance and consult your dermatologist.

On a clean, dry scalp, apply one ampoule with the silicone-tip applicator to thinning areas, massage gently for about a minute, and leave on (do not rinse) for 12 hours. Use once a week.

Both. CosmeRNA is intended for adults of any gender experiencing visible hair thinning. Men typically treat the frontal and crown areas; women the centre part.

Skintressence is bringing CosmeRNA to India through select clinics and distributors. CDSCO cosmetic registration is in progress — register your interest and we'll notify you at launch.

Use the “Become a Stockist” form. Our team will share wholesale terms, training and clinical materials, and reliable supply of authentic imported stock.